Scancell Holdings PLC (LON:SCLP)

Scancell Holdings PLC (LON:SCLP)

Share Price
8.50 p
0.3 (3.66 %)
Market Cap
£39.56 m
Proactive Investors - Run By Investors For Investors

Scancell Holdings PLC

Cancer remains one of the world’s most significant diseases. A key challenge in the fight against cancer is that many tumours continue to grow by successfully evading the body’s own natural defence mechanism - the immune system. Scancell’s mission is to overcome this breach in our defences by developing products that stimulate the immune system to treat or prevent cancer.

Market: LSE:SCLP
52-week High/Low: 13.90p / 3.00p
Sector: Pharma & Biotech
Market Cap: £39.56 m
col 3
col 4
col 5
col 6

Scancell Holdings PLC RNS Announcements

Date Epic Announcement
01/07/2019 SCLP H1 2019 Business Update
18/06/2019 SCLP Holding(s) in Company
18/06/2019 SCLP Board Appointment
17/06/2019 SCLP Holding(s) in Company
14/06/2019 SCLP Second Price Monitoring Extn
14/06/2019 SCLP Price Monitoring Extension
13/06/2019 SCLP Share Subscription and Issue of Equity to Vulpes
29/05/2019 SCLP Second Price Monitoring Extn
29/05/2019 SCLP Price Monitoring Extension
20/05/2019 SCLP Scancell and CRUK provide an update on SCIB2
10/05/2019 SCLP Clinical Advisory Board and Update on Modi-1
25/04/2019 SCLP UK approval to start SCIB1 Phase 2 trial
08/04/2019 SCLP Japan patent for Moditope immunotherapy platform
21/03/2019 SCLP Professor Lindy Durrant receives Waldenström award
20/03/2019 SCLP Scancell strengthens IP portfolio
05/03/2019 SCLP Holding(s) in Company
04/03/2019 SCLP Second Price Monitoring Extn
04/03/2019 SCLP Price Monitoring Extension
21/02/2019 SCLP Change of Auditor
31/01/2019 SCLP Interim Results
23/01/2019 SCLP Update on Cancer Research UK's Grand Challenge
21/01/2019 SCLP Appoints Heads of Research and Manufacturing
12/11/2018 SCLP Scancell to Present at Two Conferences
01/11/2018 SCLP Scancell to present at Proactive Investors Forum
30/10/2018 SCLP Results of AGM
30/10/2018 SCLP Identification of 2nd Moditope Cancer Vaccine
24/10/2018 SCLP Second Price Monitoring Extn
24/10/2018 SCLP Price Monitoring Extension
24/10/2018 SCLP Update on SCIB1 Phase 2 Clinical Study
05/10/2018 SCLP Notice of AGM

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use